$FRSX

Foresight Autonomous Holdings Ltd. American Depositary Shares (NASDAQ:FRSX) Trading 2% Higher – Still a Buy?

Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) shares rose about 2% to $2.04 on Thursday, after closing at $2.00. Trading volume was 115,055 shares, up 172% versus the average. Weiss Ratings reiterated a “sell (e+)” rating. For the March quarter, the company reported EPS of -$0.02 and revenue of $0.06M. Yorkville Advisors Global LP bought 85,000 shares (~$110,000), per an SEC filing.

Original reporting
Published May 29, 2026, 5:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 6:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Foresight Autonomous Holdings Ltd. American Depositary Shares (NASDAQ:FRSX) Trading 2% Higher – Still a Buy? — source image
Decision brief

The 30-second read

$FRSXBearishLow
01

Why it matters

The article frames near-term trading around (1) an intraday +2% move on elevated volume, (2) a reiterated sell rating, and (3) last quarter’s results showing EPS beat but revenue miss.

02

Market read

For traders, the actionable elements are the intraday momentum/volume and the juxtaposition of a sell rating with a small institutional buy and prior-quarter EPS/revenue discrepancy.

03

What to watch

The stock’s very low market cap and small absolute price level mean technical flows/liquidity can dominate short-term moves, making the +2% reaction less fundamental.

Relevance 7/10Novelty 4/10Timing: during Thursday session (intraday move)

Background

FRSX is an Israel-based vision/sensing technology company for driver assistance and autonomous vehicles, with a US-listed ADR.

Company-level read

Ticker impact

$FRSXBearishMedium confidence
Context

FRSX is the article’s subject, reporting a ~2% intraday rise plus a reiterated “sell (e+)” rating and recent quarterly EPS/revenue results.

Expected impact

Choppy/mean-reverting price action likely; upside attempts may fade unless follow-on fundamentals improve.

Evidence & confidence

The piece combines a small price move with a reiterated sell rating and weak revenue (revenue $0.06M vs $0.13M est.), which typically caps sustained upside absent new catalysts.

Market effects

Limited read-across to autonomous/driver-assistance vision/iDAR peers because the article is single-name and not a sector catalyst.

No direct regional macro linkage; company is Israel-based but the trading trigger is US-listed ADR price/ratings.

Minimal global relevance beyond small-cap sentiment and liquidity dynamics.

Counterpoint

The hedge-fund stake (85,000 shares) could signal selective accumulation, potentially supporting dips despite the sell rating.

Key entities

  • FRSX

    Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX), subject of the price move, rating reiteration, and prior-quarter results.

  • Yorkville Advisors Global LP

    Reported new position of 85,000 shares (~$110k) in the most recent SEC filing.

  • Weiss Ratings

    Reiterated a “sell (e+)” rating in a research note dated April 21.

Related articles

$VWAVMedAI 9/10

VisionWave Brings AI-based Sensing Capabilities for the Defense and Security Sector by Acquiring a Controlling Interest in Foresight Autonomous

VisionWave Holdings (NASDAQ: VWAV) said it signed a definitive agreement to acquire a controlling stake in Foresight Autonomous Holdings (NASDAQ: FRSX). VisionWave will exchange about $17.5 million of its shares for up to 52% of Foresight, with 46% at closing and 6% after a commercial milestone. Stage 1 is expected in 45–60 days; both firms remain independent.

$VWAVMedAI 9/10

VisionWave Holdings (Nasdaq: VWAV) Strengthens Position in AI-Based Defense Tech with Foresight Autonomous Acquisition

VisionWave Holdings (Nasdaq: VWAV) said it signed a definitive agreement to acquire up to 52% of Foresight Autonomous Holdings (Nasdaq: FRSX) via a two-stage share exchange. VisionWave will issue about $17.5 million of its shares for 46% initially, with an additional 6% for a commercial milestone, plus up to $3 million in equity grants. Stage 1 is expected in 45–60 days, subject to approvals.

$BTGMedAI 8/10

B2Gold Shares Surge 23% After Mali Permit Boosts Fekola Growth Outlook

B2Gold’s shares (BTG) rose 23.1% to $5.03 on Aug. 7 after Mali issued the Menankoto permit for the Fekola mine. B2Gold said Fekola Regional targets over 150,000 ounces annually from 2028 and tightened 2026 production guidance to 820,000–920,000 ounces. Adjusted EPS was $0.03 vs $0.07 consensus; cash was $287m.

$GDDYMed

Wall Street Is Losing Confidence in GoDaddy’s (GDDY) AI Strategy. Should Investors?

GoDaddy (NYSE:GDDY) reported Q results of $1.83 EPS and about $1.30B revenue, both above consensus, but the stock fell about 12%. Bookings rose 6% to $1.4B, while Applications and Commerce bookings growth slowed to 7% from 9%. Analysts cited concerns over agentic AI transition noise; management is accelerating Airo and cutting legacy investment. Q3 revenue guidance is $1.32B-$1.34B.

$BAMed

Boeing's 777X Headache Just Got Worse: Lufthansa Says No Thanks

Lufthansa said it will not accept the earliest built examples of Boeing’s 777-9, joining Emirates, as some aircraft have been in storage since 2019-2020. Boeing’s 777X program remains uncertified and is now about 6-7 years behind schedule, with certification targeted for late 2026 or early 2027 and first Lufthansa deliveries in Q1 2027. Boeing took a $4.9B pre-tax charge in 2025.